USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
Strategic Analysis of the European Markets for Theranostics
Strategic Analysis of the European Markets for Theranostics
RELEASE DATE
26-May-2009
26-May-2009
REGION
Europe
Europe
Research Code: M3C3-01-00-00-00
SKU: HC01784-EU-MR_06612
$4,950.00
Special Price $3,712.50 save 25 %
In stock
SKU
HC01784-EU-MR_06612
Description
This strategic analysis service provides a detailed analysis of the European theranostics market. An indepth analysis of marketing parameters coupled with competitive factors and strategies for sustained market prevalence are reported.
Table of Contents
Overview
- Overview
Research Scope and Methodology
- Research Scope and Methodology
Background and Applications of Theranostics
- Benefits of Theranostics
- Test Categories
- Stakeholder Analysis
- Pharma-diagnostic Convergence
- Opportunities
- Role in Pharmaceutical Industry
- Application in Drug Development Process
Key Industry Challenges and Recommendations
- Industry Challenges
Key Market Dynamics: Drivers and Restraints
- Drivers and Restraints
Key Disease Areas:Role of Theranostics
- Disease Areas
Special Focus:Oncology
- Oncology
- Recent Advances in Cancer Theranostics
Competitive Overview
- Competitive Overview
- Drugs with Companion Tests
Regulatory Scenario : FDA and EMEA Perspective
- Regulatory Scenario
SWOT Analysis
- SWOT Analysis
Conclusion
- Conclusion
Decision Support Database
- Decision Support Database
Key Industry Participants
- Key Industry Participants
Popular Topics
This strategic analysis service provides a detailed analysis of the European theranostics market. An indepth analysis of marketing parameters coupled with competitive factors and strategies for sustained market prevalence are reported.
| No Index | No |
|---|---|
| Podcast | No |
| Industries | Healthcare |
| WIP Number | M3C3-01-00-00-00 |
| Is Prebook | No |